There are ethnic differences in the timing of sexual maturation. However, averages of sexual maturity rating (SMR) for Korean adolescents were not available until recently. The purpose of this study was to determine averages for the SMR of adolescent girls and boys in Korea. The study population included 3,249 boys and 3,337 girls. The sample comprised 2,406 from the Seoul area, 2,441 from a medium-sized city and 1,739 from rural areas. Data were obtained through questionnaires and physical examinations for SMR given by pediatricians from 1991 to 1992. Sexual maturity was graded using the Tanner scales. This was a cross-sectional study. In boys, the first growth of the testes (SMR 2) was observed at a mean age 12.7 years (from 10.4 to 15.1 years of age for 95% of them). SMR 3 and SMR 4 of genitalia were 14.2+/-1.4, 15.4+/-1.3 years of age, respectively. Adult genitalia (SMR 5) was observed from 14 to 18.2 with a mean age of 16.1 years. SMR 2 of pubic hair was at a mean age of 13.2 years, and SMR 3,4, and 5 were 14.4+/-1.4, 15.6+/-1.2, 16.0+/-1.0 years of age, respectively. In girls, the mean age for breast budding (SMR 2) was 11.0 years with a range of 8.9 years to 13.1 years for 95% of them. SMR 3,4, and 5 for breast were 12.6+/-1.4, 14.2+/-1.5, 15.7+/-1.1 years of age, respectively. SMR 2,3,4, and 5 for pubic hair were 12.9+/-1.8, 14.5+/-1.5, 15.1+/-1.3, 16.0+/-1.0 years of age, respectively. Tanner stages for breast and pubic hair in girls, and genitalia and pubic in boys did not agree well within one ordinal rank. Average length of time from SMR 2 to 5 was 3.3 years for boys and 5.0 years for girls. Mean age of menarche was 12.8 years (from 10.8 to 14.8 years of age for 95% of them). Mean of menarcheal age was significantly different, geographically (12.6 years Seoul, 12.9 medium-sized city, and 12.9 rural area) (P<.0001). Menarche occurred 1.7% on breast SMR 2, 41.5% on SMR 3, 85.9% on SMR 4, 99.3% on SMR 5. In conclusion, this findings might be interpreted as providing averages of SMR for Korean girls and boys in adolescence.
Adolescent* ; Adult ; Breast ; Cross-Sectional Studies ; Female* ; Genitalia ; Hair ; Humans ; Korea* ; Menarche ; Physical Examination ; Surveys and Questionnaires ; Seoul ; Sexual Maturation ; Testis ; Weights and Measures

PURPOSE: To evaluate whether or not previously known CT criteria for differentiating malignant and benign pleural diseases are useful in the differentiation of diffuse malignant pleural diseases and tuberculosis. MATERIALS AND METHODS: We retrospectively analyzed CT scans of 42 patients comprising 20 cases of malignant pleural diseases and 22 cases of tuberculous pleural diseases, according to previously known CT criteria for differentiating malignant and benign pleural diseases. RESULTS: The most common shape of pleural effusion was crescentic in malignant pleural diseases and loculated in tuberculosis. The aggressive nature of pleural effusion, pleural rind, and pleura thickenign was 1.5 times more frequently observed in malignant pleural diseases than in tuberculosis. Smooth thickening or smooth nodular pleural thickening and extrapleural deposition of fat were 1.5 times more frequently found in tuberculous than in malignant pleural diseases. Interruption of pleural thickening was found twice as frequently in malignant pleural diseases as in tuberculosis. Decreased lung volume was found twice as frequently in tuberculous as in malignant pleural diseases. Anatomical mediastinal pleural involvement was three times, and irregular nodular pleural thickening nine times more frequent in malignant pleural diseases than in tuberculosis. The sensitivity and specificity of CT findings above 70%, and thus suggesting malignant pleural diseases, were as follows: 1) aggressive nature of pleural fluid collection extending to the azygoesophageal recess or tongue of the lung (51.5%, 75%); 2) involvement of anatomical mediastinal pleura (69.2%,73.7%); 3) irregular nodular pleural thickening (87.5%, 69%). CONCLUSION: Although there in overlap between previously known CT criteria for the differentiation of benign and malignant pleural diseases, the aggressive nature of pleural fluid collection extending to the azygoesophageal recess or tongue of the lung, the involvement of anatomical mediastinal pleura and irregular nodular pleural thickening may suggest malignant pleural diseases.
Humans ; Lung ; Pleura ; Pleural Diseases* ; Pleural Effusion ; Retrospective Studies ; Sensitivity and Specificity ; Tomography, X-Ray Computed ; Tongue ; Tuberculosis*

BACKGROUND AND OBJECTIVES: To evaluate the influence of left bundle branch block (LBBB) on the coronary flow pattern of the left anterior descending coronary artery (LAD). SUBJECTS AND METHODS: 91 patients (M: F=33: 58, mean age: 64+/-14yrs) were divided into the LBBB (n=42), RV pacing (n=26) and control groups (n=23). All patients were examined by a surface ECG, and transthoracic Doppler echocardiograms performed. The QRS duration, the left ventricular ejection fraction (LVEF) and the left ventricular end diastolic volume (LVEDV) were measured. The coronary flow was measured in the distal LAD, with transthoracic Doppler echocardiography, and the percent of the diastolic flow duration (%DD) was expressed as the percentage of the diastolic duration of coronary artery flow divided by the R-R interval. RESULTS: The %DD of the LAD was significantly shorter in patients of the LBBB than the RV pacing group (59.3+/-7.6% in control group, 43.9+/-12.4% in LBBB group, 60.3+/-7.3% in RV pacing group. p<0.01) and the same in patients with a LVEF> or =50% only (58.6+/-6.0% in control group, 49.3+/-10.5% in LBBB group, 59.6+/-5.4% in RV pacing group. p<0.01). In the LBBB group, the %DD of the LAD was positively correlated with the LVEF (p<0.05, r=0.50), negatively correlated with the QRS duration (p<0.05, r=-0.41) and negatively correlated with the LVEDV (p<0.05, r=-0.57). CONCLUSION: Differing from RV pacing, LBBB can itself disturb the coronary flow of the LAD through the shortening of the diastolic duration. Furthermore, systolic dysfunction potentiates the shortening effect of the diastolic flow duration caused by LBBB. However, whether the left ventricular systolic dysfunction is the result of a coronary flow disturbance caused by LBBB, or vice versa, needs further investigation.
Bundle-Branch Block* ; Cardiac Pacing, Artificial ; Coronary Vessels* ; Diastole ; Echocardiography, Doppler* ; Electrocardiography ; Humans ; Stroke Volume ; Ventricular Function, Left

BACKGROUND AND OBJECTIVES: The treadmill exercise test (TMT) is used as a first-line test for diagnosing coronary artery disease (CAD). However, the findings of a TMT can be inconclusive, such as incomplete or equivocal results. Aortic valve sclerosis (AVS) is known to be a good predictor of CAD. We determined the usefulness of assessing AVS on 2-dimensional (2D) echocardiography for making the diagnosis of CAD in patients with inconclusive results on a TMT. SUBJECTS AND METHODS: This prospective study involved 165 consecutive patients who underwent a TMT that resulted in inconclusive findings, 2D echocardiography to detect AVS, and coronary angiography to detect CAD. Following echocardiography, AVS was classified as none, mild, or severe. CAD was defined as > or =70% narrowing of the luminal diameter on coronary angiography. RESULTS: CAD was more common in patients with AVS than in patients without AVS (75% vs. 47%, respectively, p<0.01). Multiple logistic regression analysis showed that AVS was the only independent predictor of CAD {odds ratio=8.576; 95% confidence interval (CI), 3.739-19.672}. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the presence of AVS for predicting CAD in a patient with an inconclusive TMT were 62%, 67%, 64%, 75%, and 53%, respectively. During a 1-year clinical follow-up, patients with and without AVS were similar in terms of event-free survival rates. CONCLUSION: If the results of TMT for patients with chest pain on exertion are inconclusive, the presence of AVS on echocardiography is a good predictor of CAD.
Aortic Valve ; Chest Pain ; Coronary Angiography ; Coronary Artery Disease ; Coronary Vessels ; Disease-Free Survival ; Echocardiography ; Exercise Test ; Follow-Up Studies ; Humans ; Logistic Models ; Phenobarbital ; Prospective Studies ; Sclerosis ; Sensitivity and Specificity

BACKGROUND AND OBJECTIVES: From the view point of the molecular aspects, the fate of long standing pressure and volume overloaded atrium in severe MR has not been evaluated. This study was performed to elucidate whether apoptosis of right atrial myocytes is related to atrial changes. SUBJECTS AND METHODS: The medical records of 16 patients (M: F=8: 8, mean age=52+/-12), with severe MR having undergone valve replacement surgery, were retrospectively reviewed. The subjects were divided into 2 groups according to the duration of their symptoms (group I, symptom duration less than 12 months, n=10 and group II, more than 12 months, n=6). Using the atrial myocardium specimens obtained during surgery, TUNEL assays and immunohistochemical staining were performed for the expressions of Fas, Bax and the Bcl family. RESULTS: Apoptotic indices of TUNEL assay were 31.1+/-12.6 and 4.9+/-4.3% in groups I and II, respectively (p<0.01). The Fas expressions were 42.1+/-14.4 and 27.8+/-10.5% in groups I and II, respectively (p<0.05), but in group I, with atrial fibrillation (AF), was 49.3+/-6.9%, which was higher than the 29.2+/-12.5% in group I without AF and group II (p<0.001). The Bax expression in group I patients with a left atrial size less than 4 cm was 19.2+/-10.7%, which was higher than the 7.2+/-6.2% in group I with a left atrial size more than 4 cm and group II (p<0.05). CONCLUSION: Programmed cell death of the atrial myocardium, in severe MR, might be an early molecular pathological change rather than the late sequelae. The causality between programmed cell death and electrical and structural changes of the atrium should be further investigated.
Apoptosis ; Atrial Fibrillation ; Cell Death* ; Humans ; In Situ Nick-End Labeling ; Medical Records ; Mitral Valve Insufficiency* ; Muscle Cells ; Myocardium* ; Retrospective Studies

BACKGROUND AND OBJECTIVES: The formation of thrombi on a permanent pacemaker lead has been reported as a rare complication following the implantation of a permanent pacemaker. However, there is little information about the complications related to modern cardiac pacing. The purpose of this study was to evaluate the factors associated with the formation of a lead thrombosis following the implantation of a permanent pacemaker (P-PM). SUBJECTS AND METHODS: We retrospectively reviewed the medical records of 14 patients (M:F= 6:8, mean age=46+/-11) with P-PM lead thrombus that were detected with a transthoracic echocardiography. The clinical features, type of pacemaker and echocardiographic findings of these patients were analyzed. RESULTS: All thromb us formations had developed in the right atrium (RA), and/or superior vena cava (SVC)(100%, n=14), were mainly in the proximal portion of the RA (71.4%, n=10) and on the ventricular lead (64.3%, n=9). 12 of 14 patients (85.7%), The lead thromboses were atrial fibrillation, with tachy-brady syndrome or sinus pause. Three of the patients had a total SVC obstruction and 1 a thrombus with aspergillosis. The lead thrombus in one patient was completely resolved after thrombolytic treatment. There were no significant differences in the incidences of lead thrombosis in relation to the number of implanted leads, insulation type, echocardiographic parameters. CONCLUSION: Lead thromboses might not be a rare complication following the implantation of a P-PM, and frequently occur in the right atrium of patients with atrial pathology. The necessity for thrombolytic therapy in patients with a lead thrombus should be further investigated.
Aspergillosis ; Atrial Fibrillation ; Echocardiography ; Heart Atria ; Humans ; Incidence ; Medical Records ; Pathology ; Retrospective Studies ; Thrombolytic Therapy ; Thrombosis ; Vena Cava, Superior

BACKGROUND: Coronary artery disease (CAD) has recently become one of the major causes of mortality and morbidity in Korea. However, not much epidemiologic and demographic data has yet been reported. The purpose of this study was to investigate the clinical features as well as the prognostic factors of patients with CAD. METHODS: We prospectively enrolled 1,665 consecutive patients with CAD who had been admitted to the Catholic University Hospitals from December 1999 to April 2003. RESULTS: Acute myocardial infarction (AMI) was the most common cause of admission (n=715, 42.9%). Dyslipidemia, hypertension and smoking were the most common risk factors. More than 70% of the patients who underwent percutaneous coronary intervention (PCI) received stent implantation. A total of 965 (612 males) patients were followed at least for 6 months (the mean follow-up duration was 23.8+/-12.2 months). The incidence rates of major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, target vessel revascularization) and cardiac death were 15.1% (n=146) and 2.2% (n=21), respectively. There was no difference in overall survival between the patients treated with medical therapy and those treated with PCI. By Cox regression analysis, the independent prognostic factors for MACE were PCI (95% CI: 1.75-4.85; p<0.01) and multivessel disease (95% CI: 1.03-2.04; p<0.05), and the independent prognostic factors for cardiac death were medical therapy (95% CI: 1.08-14.41; p<0.05) and old age (95% CI: 1.13-16.13; p<0.05). CONCLUSIONS: There was no difference in overall survival between the patients treated with medical therapy and those treated with PCI. However, PCI was superior to medical therapy for preventing death of the patients with acute coronary syndrome.
Acute Coronary Syndrome ; Coronary Artery Disease* ; Coronary Disease ; Coronary Vessels* ; Death ; Dyslipidemias ; Follow-Up Studies ; Heart* ; Hospitals, University ; Humans ; Hypertension ; Incidence ; Korea ; Mortality ; Myocardial Infarction ; Percutaneous Coronary Intervention ; Prognosis ; Prospective Studies ; Risk Factors ; Smoke ; Smoking ; Stents